TNON — Tenon Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $2.27m
- -$2.11m
- $2.93m
Annual cashflow statement for Tenon Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.586 | -0.705 | -7.08 | -18.9 | -15.6 |
| Depreciation | |||||
| Non-Cash Items | 0.082 | 0.184 | 2.33 | 5.09 | 4.37 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.269 | 0.354 | 0.452 | 1.72 | -1.17 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -0.235 | -0.167 | -4.29 | -12 | -12.2 |
| Capital Expenditures | — | — | -0.102 | -0.847 | -0.361 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -4.4 | -2.04 | 6.5 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | — | — | -4.5 | -2.88 | 6.14 |
| Financing Cash Flow Items | 0 | -0.052 | -0.357 | -0.025 | -0.509 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.321 | 0.255 | 11.5 | 14.1 | 6.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.087 | 0.094 | 2.67 | -0.788 | 0.299 |